Darolutamide 300 mg Clinical Trials
3 recruitingDrug
Phase 33
Showing 1–3 of 3 trials
Recruiting
Phase 3
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
Prostate Cancer Metastatic
UNICANCER300 enrolled95 locationsNCT04916613
Recruiting
Phase 3
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
Prostatic Cancer, Castration-Resistant
UNICANCER336 enrolled4 locationsNCT06276465
Recruiting
Phase 3
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases
Prostate Cancer
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie152 enrolled1 locationNCT05116475